IBDEI380 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,51417,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,51417,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,51418,0)
 ;;=D86.85^^193^2507^42
 ;;^UTILITY(U,$J,358.3,51418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51418,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,51418,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,51418,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,51419,0)
 ;;=D86.83^^193^2507^40
 ;;^UTILITY(U,$J,358.3,51419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51419,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,51419,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,51419,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,51420,0)
 ;;=D84.1^^193^2507^16
 ;;^UTILITY(U,$J,358.3,51420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51420,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,51420,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,51420,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,51421,0)
 ;;=D81.810^^193^2507^5
 ;;^UTILITY(U,$J,358.3,51421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51421,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,51421,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,51421,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,51422,0)
 ;;=E88.01^^193^2507^2
 ;;^UTILITY(U,$J,358.3,51422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51422,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,51422,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,51422,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,51423,0)
 ;;=J09.X1^^193^2507^25
 ;;^UTILITY(U,$J,358.3,51423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51423,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,51423,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,51423,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,51424,0)
 ;;=J09.X2^^193^2507^26
 ;;^UTILITY(U,$J,358.3,51424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51424,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,51424,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,51424,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,51425,0)
 ;;=J09.X3^^193^2507^27
 ;;^UTILITY(U,$J,358.3,51425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51425,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,51425,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,51425,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,51426,0)
 ;;=J09.X9^^193^2507^28
 ;;^UTILITY(U,$J,358.3,51426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51426,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,51426,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,51426,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,51427,0)
 ;;=J44.9^^193^2507^14
 ;;^UTILITY(U,$J,358.3,51427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51427,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,51427,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,51427,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,51428,0)
 ;;=J44.1^^193^2507^12
 ;;^UTILITY(U,$J,358.3,51428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51428,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,51428,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,51428,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,51429,0)
 ;;=J42.^^193^2507^10
 ;;^UTILITY(U,$J,358.3,51429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51429,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,51429,1,4,0)
 ;;=4^J42.
